Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

NCT00004736 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Tuberculosis

Interventions

DRUG: Nelfinavir mesylate
DRUG: Ethambutol hydrochloride
DRUG: Isoniazid
DRUG: Pyrazinamide
DRUG: Lamivudine
DRUG: Rifabutin
DRUG: Stavudine
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)